Prostacyclin and Hypertension:
The aim of present-day treatment of hypertension is no longer as the effective reduction of blood pressure, regarded merely but as the ever-increasing application of new therapeutic prin ciples to prevent such consequences of hypertension as left heart hypertrophy, medial hypertrophy of the vessels...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1990
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | The aim of present-day treatment of hypertension is no longer as the effective reduction of blood pressure, regarded merely but as the ever-increasing application of new therapeutic prin ciples to prevent such consequences of hypertension as left heart hypertrophy, medial hypertrophy of the vessels and ar teriosclerosis. In this context special attention has been di rected to stimulation of the endogenous vasocilator hormonal systems such as the prostaglandins. The great interest in our book, which has meanwhile appeared in a French edition, seems to confirm this trend and has encouraged us to include in the book the new findings published in the last twelve months. These changes and additions maintain the current status of the book and provide an even more complete survey of the available information about prostacyclin in hyperten sion. We wish to thank all those colleagues who have made useful suggestions for this second edition, as well as Springer Verlag and its associates, who ensured a uniformly smooth passage in the production of the book. Cologne and MUnster, January 1990 Gerd Bonner Karl-Heinz Rahn v Preface to the First Edition Diseases of the heart and circulation currently constitute the commonest causes of death in our population. Hypertension, as evidenced by a pathologic increase in blood pressure, is one of the most important risk factors. Primary hypertension can be established in about 15 % of adults. Patients with hyperten sion usually feel well subjectively and only rarely complain of symptoms |
| Beschreibung: | 1 Online-Ressource (XII, 90 p) |
| ISBN: | 9783642956089 |
| DOI: | 10.1007/978-3-642-95608-9 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046143937 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1990 |||| o||u| ||||||eng d | ||
| 020 | |a 9783642956089 |9 978-3-642-95608-9 | ||
| 024 | 7 | |a 10.1007/978-3-642-95608-9 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-642-95608-9 | ||
| 035 | |a (OCoLC)1118997934 | ||
| 035 | |a (DE-599)BVBBV046143937 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.12 |2 23 | |
| 100 | 1 | |a Bönner, Gerd |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Prostacyclin and Hypertension |c by Gerd Bönner, Karl-Heinz Rahn |
| 264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1990 | |
| 300 | |a 1 Online-Ressource (XII, 90 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a The aim of present-day treatment of hypertension is no longer as the effective reduction of blood pressure, regarded merely but as the ever-increasing application of new therapeutic prin ciples to prevent such consequences of hypertension as left heart hypertrophy, medial hypertrophy of the vessels and ar teriosclerosis. In this context special attention has been di rected to stimulation of the endogenous vasocilator hormonal systems such as the prostaglandins. The great interest in our book, which has meanwhile appeared in a French edition, seems to confirm this trend and has encouraged us to include in the book the new findings published in the last twelve months. These changes and additions maintain the current status of the book and provide an even more complete survey of the available information about prostacyclin in hyperten sion. We wish to thank all those colleagues who have made useful suggestions for this second edition, as well as Springer Verlag and its associates, who ensured a uniformly smooth passage in the production of the book. Cologne and MUnster, January 1990 Gerd Bonner Karl-Heinz Rahn v Preface to the First Edition Diseases of the heart and circulation currently constitute the commonest causes of death in our population. Hypertension, as evidenced by a pathologic increase in blood pressure, is one of the most important risk factors. Primary hypertension can be established in about 15 % of adults. Patients with hyperten sion usually feel well subjectively and only rarely complain of symptoms | ||
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Endocrinology | |
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Toxicology | |
| 650 | 4 | |a Endocrinology | |
| 650 | 0 | 7 | |a Hypertonie |0 (DE-588)4026372-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Prostacyclin |0 (DE-588)4130420-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Prostacyclin |0 (DE-588)4130420-2 |D s |
| 689 | 0 | 1 | |a Hypertonie |0 (DE-588)4026372-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Rahn, Karl-Heinz |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540521402 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642956096 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-95608-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031524120 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-642-95608-9 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180478659395584 |
|---|---|
| any_adam_object | |
| author | Bönner, Gerd Rahn, Karl-Heinz |
| author_facet | Bönner, Gerd Rahn, Karl-Heinz |
| author_role | aut aut |
| author_sort | Bönner, Gerd |
| author_variant | g b gb k h r khr |
| building | Verbundindex |
| bvnumber | BV046143937 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-642-95608-9 (OCoLC)1118997934 (DE-599)BVBBV046143937 |
| dewey-full | 616.12 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.12 |
| dewey-search | 616.12 |
| dewey-sort | 3616.12 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-642-95608-9 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03329nmm a2200517zc 4500</leader><controlfield tag="001">BV046143937</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1990 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642956089</subfield><subfield code="9">978-3-642-95608-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-95608-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-95608-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118997934</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046143937</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.12</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bönner, Gerd</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prostacyclin and Hypertension</subfield><subfield code="c">by Gerd Bönner, Karl-Heinz Rahn</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XII, 90 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The aim of present-day treatment of hypertension is no longer as the effective reduction of blood pressure, regarded merely but as the ever-increasing application of new therapeutic prin ciples to prevent such consequences of hypertension as left heart hypertrophy, medial hypertrophy of the vessels and ar teriosclerosis. In this context special attention has been di rected to stimulation of the endogenous vasocilator hormonal systems such as the prostaglandins. The great interest in our book, which has meanwhile appeared in a French edition, seems to confirm this trend and has encouraged us to include in the book the new findings published in the last twelve months. These changes and additions maintain the current status of the book and provide an even more complete survey of the available information about prostacyclin in hyperten sion. We wish to thank all those colleagues who have made useful suggestions for this second edition, as well as Springer Verlag and its associates, who ensured a uniformly smooth passage in the production of the book. Cologne and MUnster, January 1990 Gerd Bonner Karl-Heinz Rahn v Preface to the First Edition Diseases of the heart and circulation currently constitute the commonest causes of death in our population. Hypertension, as evidenced by a pathologic increase in blood pressure, is one of the most important risk factors. Primary hypertension can be established in about 15 % of adults. Patients with hyperten sion usually feel well subjectively and only rarely complain of symptoms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prostacyclin</subfield><subfield code="0">(DE-588)4130420-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Prostacyclin</subfield><subfield code="0">(DE-588)4130420-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rahn, Karl-Heinz</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540521402</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642956096</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-95608-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524120</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-95608-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046143937 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:24Z |
| institution | BVB |
| isbn | 9783642956089 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524120 |
| oclc_num | 1118997934 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XII, 90 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1990 |
| publishDateSearch | 1990 |
| publishDateSort | 1990 |
| publisher | Springer Berlin Heidelberg |
| record_format | marc |
| spelling | Bönner, Gerd Verfasser aut Prostacyclin and Hypertension by Gerd Bönner, Karl-Heinz Rahn Berlin, Heidelberg Springer Berlin Heidelberg 1990 1 Online-Ressource (XII, 90 p) txt rdacontent c rdamedia cr rdacarrier The aim of present-day treatment of hypertension is no longer as the effective reduction of blood pressure, regarded merely but as the ever-increasing application of new therapeutic prin ciples to prevent such consequences of hypertension as left heart hypertrophy, medial hypertrophy of the vessels and ar teriosclerosis. In this context special attention has been di rected to stimulation of the endogenous vasocilator hormonal systems such as the prostaglandins. The great interest in our book, which has meanwhile appeared in a French edition, seems to confirm this trend and has encouraged us to include in the book the new findings published in the last twelve months. These changes and additions maintain the current status of the book and provide an even more complete survey of the available information about prostacyclin in hyperten sion. We wish to thank all those colleagues who have made useful suggestions for this second edition, as well as Springer Verlag and its associates, who ensured a uniformly smooth passage in the production of the book. Cologne and MUnster, January 1990 Gerd Bonner Karl-Heinz Rahn v Preface to the First Edition Diseases of the heart and circulation currently constitute the commonest causes of death in our population. Hypertension, as evidenced by a pathologic increase in blood pressure, is one of the most important risk factors. Primary hypertension can be established in about 15 % of adults. Patients with hyperten sion usually feel well subjectively and only rarely complain of symptoms Cardiology Pharmacology/Toxicology Endocrinology Toxicology Hypertonie (DE-588)4026372-1 gnd rswk-swf Prostacyclin (DE-588)4130420-2 gnd rswk-swf Prostacyclin (DE-588)4130420-2 s Hypertonie (DE-588)4026372-1 s DE-604 Rahn, Karl-Heinz aut Erscheint auch als Druck-Ausgabe 9783540521402 Erscheint auch als Druck-Ausgabe 9783642956096 https://doi.org/10.1007/978-3-642-95608-9 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Bönner, Gerd Rahn, Karl-Heinz Prostacyclin and Hypertension Cardiology Pharmacology/Toxicology Endocrinology Toxicology Hypertonie (DE-588)4026372-1 gnd Prostacyclin (DE-588)4130420-2 gnd |
| subject_GND | (DE-588)4026372-1 (DE-588)4130420-2 |
| title | Prostacyclin and Hypertension |
| title_auth | Prostacyclin and Hypertension |
| title_exact_search | Prostacyclin and Hypertension |
| title_full | Prostacyclin and Hypertension by Gerd Bönner, Karl-Heinz Rahn |
| title_fullStr | Prostacyclin and Hypertension by Gerd Bönner, Karl-Heinz Rahn |
| title_full_unstemmed | Prostacyclin and Hypertension by Gerd Bönner, Karl-Heinz Rahn |
| title_short | Prostacyclin and Hypertension |
| title_sort | prostacyclin and hypertension |
| topic | Cardiology Pharmacology/Toxicology Endocrinology Toxicology Hypertonie (DE-588)4026372-1 gnd Prostacyclin (DE-588)4130420-2 gnd |
| topic_facet | Cardiology Pharmacology/Toxicology Endocrinology Toxicology Hypertonie Prostacyclin |
| url | https://doi.org/10.1007/978-3-642-95608-9 |
| work_keys_str_mv | AT bonnergerd prostacyclinandhypertension AT rahnkarlheinz prostacyclinandhypertension |